相关实验视频
Updated: Sep 10, 2025

13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.8K
在COPD,喘和喘-COPD重叠患者中总抗氧化能力的比较
Melike Yüksel Yavuz1, Muzaffer Onur Turan1, Hayat Özkanay2
1Pulmonology Department, School of Medicine, İzmir Katip Çelebi University, 35620 İzmir, Türkiye.
Medicina (Kaunas, Lithuania)
|August 28, 2025
概括
慢性阻塞性肺病 (COPD) 患者的总抗氧化能力 (TAC) 与喘和喘-COPD重叠 (ACO) 患者相比较低. 较低的TAC可以帮助区分COPD和喘或ACO.
科学领域:
- 肺部医学
- 生物化学
背景情况:
- 喘,COPD和喘-COPD重叠是阻塞性肺部疾病,其特征是炎症.
- 氧化应激和抗氧化状态不平衡与这些疾病的发病有关.
研究的目的:
- 在喘,COPD和喘-COPD重叠 (ACO) 患者中研究总抗氧化能力 (TAC) 的差异.
主要方法:
- 这是一项涉及76名患者的前性横截研究.
- 使用生物化学分析仪和总抗氧化活性方法测量禁食静脉血液样本中的TAC.
主要成果:
- 与喘和ACO患者相比,COPD患者的TAC水平明显较低 (p=0. 049和p=0. 026).
- 当前和前吸烟者的TAC水平低于从未吸烟者的TAC水平 (p=0.033).
- 没有发现TAC水平与乙酸细胞数量,FEV1或FEV1/FVC比率之间的显著相关性.
结论:
- 降低TAC水平可以作为区分COPD和喘或ACO的潜在生物标志物.
- 需要进一步的研究来探索TAC在阻塞性肺病中的临床效用.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
305
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
305
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Asthma-III: Symptoms and Complications
2.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K

